2019

  • February 12, 2019

    Nemaura Reports Third Quarter 2018 Financial Results

    Loughborough, England – Nemaura Medical, Inc. (NASDAQ: NMRD) nemauramedical.com, a medical technology company focused on the development of SugarBEAT® as...

    February 11, 2019

    Nemaura Announces Dr. Fred Schaebsdau to Lead Strategy and Business Development

    Dr. Schaebsdau to Advance European Launch of SugarBEAT® Continuous Glucose Monitor   Nemaura Preparing U.S. FDA 510(k) Submission  ...

    February 7, 2019

    Nemaura Medical Announces Grant of U.S. Patent for SugarBEAT® Glucose Sensing Algorithm

    Loughborough, England – February 7, 2019 – Nemaura Medical Inc. (NASDAQ: NMRD) nemauramedical.com, a medical technology company focused on the...

    January 17, 2019

    Nemaura Medical Announces Improvement to SugarBEAT® Continuous Glucose Monitor

    Loughborough, England –Nemaura Medical, Inc. (NASDAQ: NMRD) nemauramedical.com a medical technology company focused on the development of SugarBEAT® as...